Your search returned 57 studies. (Get alerts for new studies):
- Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Conditions: Leukemia - Myelodysplastic Syndromes
Location: Jackson, Tennessee
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Tri
Conditions: Breast Cancer
Location: Jackson, Tennessee
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Jackson, Tennessee
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Jackson, Tennessee
- RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure - Anemia - Cardiovascular Disease - Ventricular Dysfunction - Congestive Heart Failure
Location: Jackson, Tennessee
- Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid
Location: Jackson, Tennessee
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Jackson, Tennessee
- Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Conditions: Venous Thrombosis
Location: Jackson, Tennessee
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Jackson, Tennessee
- Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus
Location: Jackson, Tennessee
- Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
Conditions: Type 2 Diabetes Mellitus
Location: McKenzie, Tennessee
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Jackson, Tennessee
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Jackson, Tennessee
- Bendamustine as Second-Line Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Jackson, Tennessee
- Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Conditions: Liver Cancer
Location: Jackson, Tennessee
- Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis
Conditions: Active Rheumatoid Arthritis
Location: Jackson, Tennessee
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Liver Cancer
Location: Jackson, Tennessee
- Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute M
Conditions: Leukemia
Location: Jackson, Tennessee
- A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2
Location: Lexington, Tennessee
- Evaluation of SAR153191(REGN88)(Sarilumab) on Top of Methotrexate in Rheumatoid Arthritis Patients
Conditions: Rheumatoid Arthritis
Location: Jackson, Tennessee
- Treatment With Adenosine Diphosphate (ADP) Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome
Conditions: Acute Coronary Syndrome
Location: Jackson, Tennessee
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
Location: Jackson, Tennessee
- A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer
Conditions: Colon Cancer - Rectal Cancer
Location: Jackson, Tennessee
- Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
Conditions: Lymphoma
Location: Jackson, Tennessee
- Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Canc
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer
Location: Jackson, Tennessee
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Conditions: Acute Coronary Syndrome
Location: Jackson, Tennessee
- A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Acti
Conditions: Rheumatoid Arthritis
Location: Jackson, Tennessee
- Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA)
Conditions: Early Rheumatoid Arthritis
Location: Jackson, Tennessee
- A Study of LY2127399 in Patients With Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus - Connective Tissue Disease - Autoimmune Disease
Location: Jackson, Tennessee
- Growth of Infants Fed an Extensively Hydrolyzed Infant Formula
Conditions: Growth
Location: Jackson, Tennessee
- Study the Effects of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Conditions: Myocardial Perfusion Imaging - Myocardial Ischemia
Location: Jackson, Tennessee
- Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Jackson, Tennessee
- LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Conditions: Irritable Bowel Syndrome
Location: Jackson, Tennessee
- Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
Conditions: Fibromyalgia
Location: Milan, Tennessee
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Conditions: Melanoma (Skin)
Location: Jackson, Tennessee
- A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate in Patients With Moderate to Severe Active Rheumatoid Ar
Conditions: Rheumatoid Arthritis
Location: Jackson, Tennessee
- Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis [PSA, PALACE 4]
Conditions: Psoriatic Arthritis
Location: Jackson, Tennessee
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Jackson, Tennessee
- Growth and Tolerance of Hypoallergenic Formulas
Conditions: Growth of Term Infants
Location: Jackson, Tennessee
- Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe
Conditions: Low Back Pain
Location: Huntingdon, Tennessee
- Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis Taking Methotrexate
Conditions: Rheumatoid Arthritis
Location: Jackson, Tennessee
- Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthriti
Conditions: Rheumatoid Arthritis
Location: Jackson, Tennessee
- A Study on The Safety of Administering MabThera/Rituxan (Rituximab) at A More Rapid Rate in Patients With Rheumatoid Arthritis (RATE-RA)
Conditions: Rheumatoid Arthritis
Location: Jackson, Tennessee
- Allopurinol Outcome Study
Conditions: Gout
Location: Jackson, Tennessee
- Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
Conditions: Lupus Erythematosus, Systemic
Location: Jackson, Tennessee
- Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Conditions: Angina Pectoris - Coronary Artery Disease - Type 2 Diabetes Mellitus
Location: Jackson, Tennessee
- The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Conditions: Chronic Idiopathic Constipation
Location: Jackson, Tennessee
- Prematurity and Respiratory Outcomes Program (PROP)
Conditions: Prematurity - Respiratory Disease
Location: Jackson, Tennessee
- Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
Conditions: Coronary Artery Disease - Angina Pectoris
Location: Jackson, Tennessee
- Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis
Conditions: Gastroparesis - Diabetes Mellitus, Type 1 - Diabetes Mellitus, Type 2
Location: Jackson, Tennessee
- Improving Prematurity-Related Respiratory Outcomes at Vanderbilt
Conditions: Prematurity - Bronchopulmonary Dysplasia - Chronic Lung Disease of Prematurity
Location: Jackson, Tennessee
- A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis
Conditions: Colitis, Ulcerative
Location: Jackson, Tennessee
- A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Conditions: Systemic Lupus Erythematosus
Location: Jackson, Tennessee
- Combining Lesinurad With Allopurinol in Inadequate Responders
Conditions: Gout
Location: Jackson, Tennessee
- Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat
Conditions: Tophaceous Gout
Location: Jackson, Tennessee
- A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2
Location: Jackson, Tennessee
- Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis
Conditions: Ankylosing Spondyloarthritis
Location: Jackson, Tennessee
|